Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca82d85ba526a9d85bc53f9c7a5be440 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-526 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-524 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2016-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25e7be08c350f945d27dd50afe1622d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0290f0e0967cd4f1ba0b65e95c7075ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39dcf96fc837e918cd878ed2b58ce74d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f596d24b7c4258f6d708b716abd42f73 |
publicationDate |
2020-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3342784-B1 |
titleOfInvention |
Fully human antibody specifically inhibiting connexin 26 |
priorityDate |
2016-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |